key: cord-0919267-2d2y5gmg
authors: Morens, David M.; Fauci, Anthony S.
title: Emerging Pandemic Diseases: How We Got To COVID-19
date: 2020-08-15
journal: Cell
DOI: 10.1016/j.cell.2020.08.021
sha: e58e75a6c2acb6e670631a80add5170d5c54a684
doc_id: 919267
cord_uid: 2d2y5gmg

Abstract Infectious diseases prevalent in humans and animals are caused by pathogens that once emerged from other animal hosts. In addition to these established infections, new infectious diseases periodically emerge. In extreme cases they may cause pandemics such as COVID-19; in other cases, dead end infections or smaller epidemics result. Established diseases may also re-emerge, for example by extending geographically or by becoming more transmissible or more pathogenic. Disease emergence reflects dynamic balances and imbalances, within complex globally-distributed ecosystems comprised of humans, animals, pathogens, and the environment. Understanding these variables is a necessary step in controlling future devastating disease emergences.

Infectious Diseases that have Emerged in the Past. In thinking about these recent infectious disease emergences, it is necessary to first consider currently existing infectious diseases that newly emerged in the past and then over time became endemic (prevalent in humans) or enzootic (prevalent in animals) Morens et al., 2020b; Morens and Fauci, 2012; Morens et al., 2004) . Such existing diseases may provide important clues about the mechanisms of disease emergence and persistence, and why thus far we have been largely unable to prevent and control many of them.

The fact that many past emerging infectious microbes and viruses (hereafter grouped together as "microbes") have adapted to stable coexistence with humans is evidenced by the presence of endogenous retroviruses in human DNA (Johnson, 2019) , and by latently-infecting herpesviruses such as herpes simplex (HSV), cytomegalovirus (CMV), Epstein-Barr virus (EBV), and varicella-zoster virus (VZV). VZV, for example, is a highly cytolytic, highly contagious, and potentially fatal J o u r n a l P r e -p r o o f 8 virus that has adapted to long-term survival in human populations via a complex survival mechanism. Unlike other highly contagious humanadapted respiratory viruses such as measles ̶ whose survival requires very large populations in order to avoid exhausting susceptible persons ̶ VZV establishes latent non-cytolytic infections in human ganglia, periodically reactivating into an infectious/cytolytic form (zoster) that can be transmitted -even in populations without circulating varicella ("chicken pox") -to new birth cohorts of susceptible persons to be manifested as highly contagious varicella.

Human infectious agents such as retroviruses, herpesviruses, and many others, tell us that long-ago emergences of certain diseases can result in long-term microbial survival by co-opting certain of our genetic, cellular, and immune mechanisms to insure their continuing transmission. In the terminology of British biologist Richard Dawkins, evolution occurs at the level of gene competition and we, phenotypic humans, are merely genetic "survival machines" in the competition J o u r n a l P r e -p r o o f 9 between microbes and humans (Dawkins, 1976) . It may be a matter of perspective who is in the evolutionary driver's seat. This perspective has implications for how we think about and react to emerging infectious disease threats.

From the human point of view, the fact that modern endemic diseases emerged and became established, at some unobserved time in the past [Table 1 (Morens et al., 2004) ], and that some of these diseases survived by adopting complicated long-term survival strategies, provides a compelling rationale for dual strategies for immediate and long-term control. First, in the immediate sense, it is important to mitigate spread of infection, illness, and death. Second, it is critical to prevent the persistence of microbes that may lead to additional emergences that are cumulatively as deadly, or more so, than the original eme rgences (Dobson AP, 1996) . That viral genetic descendants of the 1918 influenza pandemic virus are still causing seasonal outbreaks throughout the world, and still killing cumulatively J o u r n a l P r e -p r o o f 10 millions of people a century later (Morens DM, 2020) , is a powerful reminder that single disease emergences can have consequences beyond immediate morbidity and mortality. In the ancient ongoing struggle between microbes and man, genetically more adaptable microbes have the upper hand in consistently surprising us and often catching us unprepared.

The latest example of this, the COVID-19 pandemic, which emerged in December 2019, is still exploding globally [ Figure 1 ]. To date, over 16 million cases have been detected, with over 700,000 deaths recorded (Organization, 2020) ; however, these are undoubtedly significant undercounts, reflecting early and still problematic access to diagnostic testing coupled with incomplete diagnoses of fatal cases. As COVID-19 is caused by a novel virus (SARS-CoV-2) producing a spectrum of disease whose clinical, pathologic, and epidemiologic patterns have never before been observed, we are gaining insights only incrementally.

At some time in the future we will be better able to compare and J o u r n a l P r e -p r o o f 11 contrast COVID-19 to other important emerging diseases; however, at this time we are still just entering a steep learning curve that will surely keep surprising us as we struggle to control what is already among the deadliest pandemics of the past century.

The onceemerging/now prevalent diseases mentioned above, e.g., many viruses causing upper respiratory, enteric, or dermal/mucosal infections, are not considered to be truly emerging even when they vary seasonally or geographically; however, upon this background of existing diseases, new diseases still continue to emerge.

Emerging diseases have been categorized as newly emerging, reemerging, or "deliberately-emerging", that is, associated with bioterrorism [Table 2, Figure 2 Morens et al., 2004 Morens et al., , 2008a . To these we add "accidentally emerging" humangenerated diseases, such as repeated emergences of vaccine-derived polioviruses (VDPVs) resulting from naturally occurring back-mutations 12 of live virus vaccines, as well as a live human-engineered vaccine that escaped to cause a new epizootic disease: naturally-transmitted vaccinia (Lum et al., 1967) . Although these four categories are distinct, they are also inter-related: newly emerging diseases can persist and then re-emerge, and can also become agents of deliberate or accidental release. An example crossing the latter two categories is the 1979 Sverdlovsk (now Yekaterinaberg) anthrax accident, in which an unintentional explosion in a Russian bioweapons factory released anthrax into the air, resulting in at least 100 human deaths (Meselson et al., 1994) . Such deliberately-emerging and accidentally-emerging diseases represent a special case in which emergence/epidemicity is best prevented by global biosafety cooperation.

Among possible ways to achieve such cooperation are by strengthening the United Nations and its agencies, particularly the A fifth related category, significant because it emphasizes the importance of responding to disease emergence threats with countermeasures, is that of diseases that are "de-emerging", i.e., those that have been eliminated or even eradicated, or are in the process of elimination and/or eradication [ Table 3 (Dowdle and Cochi, 2011; Hopkins, 2013; Tomori, 2011) . Smallpox and the veterinary disease rinderpest were declared eradicated in 1980 , respectively. SARS, which emerged in 2002 -2003 and spread globally to 29 countries, infecting 8,096 people and killing 813, was controlled and ultimately 14 eliminated from human spread by effective public health efforts (Cui et al., 2019) . By some definitions, SARS was thereby eradicated, although it presumably remains in enzootic circulation and could re-emerge from nature, as Ebola viruses have been doing for the past 44 years (Baseler et al., 2017) .

Other diseases nearing eradication include dracunculiasis, lymphatic filariasis, measles, polio, and rubella [ Table 3 ]. Such successes in eradication/control reflect the availability of improved tools and strategies for prevention and control, as well as international public and private efforts to reduce their substantial mortality and morbidity. Successes in eradication and control of infectious diseases remind us that we are not helpless in the face of emerging diseases.

Eradicating/controlling existing diseases, and preventing/controlling newly-emerging diseases, are related efforts demanding the same scientific, public health, and civic/political focus, that will be required to successfully address this formidable challenge. zoonotic (Woolhouse and Gowtage-Sequeria, 2005; . Such zoonotic microbial emergences are often associated with mutational mechanisms allowing host-switching from animals to humans, as discussed below.

The triad of causations of emerging and other diseases, as conceptualized for over a century, represents interactions between infectious agents, their hosts, and the environment [ Figure 3 ]. This conceptualization acknowledges the reality that while infectious diseases themselves are necessarily "caused" by microbial agents, J o u r n a l P r e -p r o o f 16 emergences that produce epidemics and pandemics are also significantly determined by co-factors related to the host and to hostenvironmental interactions (Centers) .

Diseases. Considerations of the emergences of infectious diseases begin with the infectious agent itself. Although many established diseases, such as tuberculosis, malaria, and cholera, are bacterial or protozoal, and yet others are caused by fungi (e.g., cryptococci) or agents such as Rickettsia or prions, the majority of important newlyemerging and re-emerging diseases in the past century have been viral.

This review therefore emphasizes viruses, including SARS-CoV, and SARS-CoV-2, influenza, arboviruses, and hemorrhagic fever viruses, among others.

Genetic instability of micro-organisms is an inherent property allowing rapid microbial evolution to adapt to ever-changing ecologic niches. This is particularly true of RNA viruses such as influenza viruses, receptors, co-receptors, and of countless viruses able to utilize them, reflecting that "viruses have deep evolutionary roots in the cellular world" (Baranowski et al., 2001) . This is exemplified by the SARS-like bat β-coronaviruses, or sarbecoviruses, whose receptor binding domains appear to be hyper-evolving by sampling a variety of mammalian receptors (Hu et al., 2017) .

Many viruses enter cells via phagocytic or pinocytic endocytosis, the latter including clathrin-mediated or claveolin-mediated endocytosis, yet other viruses enter cells via fusion or direct penetration . SARS-CoV and -CoV-2 are β-J o u r n a l P r e -p r o o f 19 coronaviruses that enter human cells via angiotensin-converting enzyme-2 (ACE-2) receptors, whose non-human counterpart receptors are ubiquitous on cells of other species (Cui et al., 2019; Hasan et al., 2020) . This means that coronaviruses of many other mammalian species may essentially be pre-adapted to human infectivity. Evidence suggests that there are many bat coronaviruses pre-adapted to emerge, and possibly to emerge pandemically (Andersen et al., 2020; Hasan et al., 2020; Hu et al., 2017; Menachery et al., 2016; Wang et al., 2018; Zhou et al., 2020a) .

Influenza A viruses (IAVs) infect cells via binding to terminal sialic acids found on lumenal respiratory epithelial cells of avian as well as mammalian and human hosts, and contain a neuraminidase that cleaves these same receptors to allow viral release, which facilitates onward viral transmission (Morens DM, 2020; Taubenberger et al., 2019) . Since sialic acids are found on a wide variety of mammalian and non-mammalian cells, it is not surprising that many viruses attach to J o u r n a l P r e -p r o o f 20 these receptors, although viral affinities to receptors are complicated.

For example, in vitro lectin assays suggest variable affinities of influenza for different types of terminal sialic acids, e.g., those with α-2,3 (ostensibly avian) and those with α-2,6 (ostensibly mammalian) linkages. However, autopsy studies have confirmed fatal human infections caused by IAVs that prefer either receptor, reflecting the complexity of virus-host interactions across the animal kingdom.

Yet another aspect of infecting viruses is that some (e.g., HIV, influenza) express immunodominant epitopes on external proteins that dominate the elicitation of immune responses, resulting in less robust immune responses to other, often adjacent, epitopes. This may have the effect of blunting, or limiting the breadth of, an otherwise optimal host immune response. Almost all viruses have proteins that inhibit innate protective host responses, such as the host interferon response (Blanco-Melo et al., 2020; Mesev et al., 2019) . Some viruses are able to infect FcR bearing cells via antibody-dependent infection enhancement J o u r n a l P r e -p r o o f 21 or ADE -a mechanism by which virus-IgG complexes are "tied down"

by FcRs to the cell surface, facilitating cell entry via another receptor (Morens, 1994; Sullivan, 2001) . During the 2002-2003 SARS epidemic, it was found that both post-infectious and vaccine-elicited antibody caused in vitro ADE with SARS-CoV (Jaume et al., 2012; Wang et al., 2016; Wang et al., 2014; Yip et al., 2014) . It is not known whether this phenomenon, studied mostly in vitro, has implications for natural human coronavirus infections or vaccinations (Wan et al., 2020) ; however, it does represent a potential safety concern associated with vaccine development for SARS-CoV and SARS CoV-2.

In considering SARS-CoV-2 vaccine development and antibody treatment/prophylaxis, it is also of some concern that natural infection with the feline coronavirus (FECV) initiates a non-fatal infection that sometimes leads to development of viral variants (known as feline infectious peritonitis viruses [FIPV] ) that are macrophage-tropic, and that can bind to host anti-spike protein antibody (antibody against the J o u r n a l P r e -p r o o f 22 external viral protein that attaches to ACE-2 receptors and elicits protective immunity) to allow viruses to enter macrophages via FcRs (ADE), leading to a distinct and universally-fatal disease known as feline infectious peritonitis, or FIP (Vennema et al., 1990; Weiss and Scott, 1981) . Post-infectious gene-editing by the host has also been proposed as a mechanism for development of subacute sclerosing panencephalitis (SSPE), a fatal human disease associated with persistent natural measles virus infection complicated by generation of hostedited mutant viruses (Baranowski et al., 2001; Cattaneo et al., 1986 ).

This represents yet another variation on mechanisms of viral emergence (Baranowski et al., 2001; Cattaneo et al., 1986; Novella et al., 2011) . Fortunately, viruses such as those that cause SSPE, derived from in-host gene editing, are not necessarily transmissible.

In experimental studies, early FIPV-associated feline deaths result from both FIPV spike protein vaccination and passive transfusion with anti-FIPV antibody (Vennema et al., 1990; Weiss and Scott, 1981) . humans. On the one hand, preliminary data suggest that SARS-CoV-2 may elicit an unbalanced innate immune response associated with decreased expression of interferons I and III, and with increased inflammatory cytokine production (Mesev et al., 2019) , consistent with preliminary COVID-19 findings (Vanderheiden et al., 2020) . On the other hand, preliminary data suggest that viral-bacterial copathogenesis may be of somewhat less concern with SARS-CoV-2 than with influenza, measles, and other pathogenic respiratory viruses, With regard to coronavirus disease severity, it is worth considering the conventional wisdom (not always correct) that viruses that kill their hosts limit their own ability to be transmitted; and that if transmitted person-to-person, they would be expected to be selected for attenuation of pathogenicity over time. It is conceivable that the four endemic coronaviruses of humans ̶ the β-coronaviruses OC43 and HKU1, and the α-coronaviruses 229E and NL63 ̶ emerged long ago as zoonotic and perhaps highly pathogenic viruses that evolved into attenuated forms over time (Anthony et al., 2017; Cui et al., 2019) . Disease severity thus reflects a balancing act between killing or incapacitating hosts, on the one hand, and optimizing microbial transmission, and therefore survival, on the other. Similar principles may also apply to non-viral diseases with environmental modes of transmission: for example, with enzootic anthrax, host-killing may be an important transmission mechanism, as rotting carcasses leave anthrax J o u r n a l P r e -p r o o f 28 spores in the ground to reignite future infections (Turner et al., 2014) .

Agent-host interaction variables are often exceedingly complex.

Host variables that underlie the emergence of infectious diseases include those variables specific to individuals within the host population and those variables that relate to the host population as a whole Morens et al., 2004 Morens et al., , 2008a Some viruses enter cells via binding to two different proximate receptors, a primary and secondary receptor, e.g., receptors for binding and for fusion (for example, numerous flaviviruses (Hamming et al., 2004) . As noted, mechanisms of viral entry into cells are exceedingly variable and complex (Hu et al., 2017; Jayawardena et al., 2020) .

Viruses may also infect macrophages and macrophage-like cells, as is the case with mosquito-borne and tick-borne flaviviruses. These viruses are injected into peri-vascular dermal tissue by their respective vectors, are taken up by dendritic cells and carried to regional lymph nodes, where they initiate systemic infection. ADE, discussed above, J o u r n a l P r e -p r o o f 31 and other ADE-like phenomena, may also facilitate cellular infection (Morens, 1994; Sullivan, 2001) . (Rieder et al., 2001) .

In the case of COVID-19, some evidence suggests the absence of pre-existing population immunity, afforded by exposure to the four endemic coronaviruses, sufficient to prevent infection (Corman et al., 2018) . Although these endemic viruses share few epitopes that crossreact significantly with SARS-CoV-2 in serologic studies, it has been speculated that endemic coronavirus cross-protection may nevertheless prevent or at least limit the severity of disease in some, especially in young persons (Nickbakhsh et al., 2020) .

There is preliminary but growing evidence that infectious disease severity or even susceptibility may in some cases be related to host genetic variables associated with the innate immune response, as is the case with epidemiologic information concerning severe disease caused by H5N1 poultry-associated influenza (Morens and Taubenberger, 2015) . Several host genes have been provisionally linked to J o u r n a l P r e -p r o o f 35 susceptibility to such severe viral disease outcomes (Nguyen et al., 2020; Tang et al., 2008) , including the interferon-related transmembrane protein 3 (IFITM3) SNP rs22522-C allele (Everitt et al., 2012 ) (Xu-Yang et al., 2016 , which has been proposed (based on very preliminary data) to be involved in severity of SARS-CoV-2 disease . In addition, differential interactions with IFITMs such as IFITM3 include inhibiting the human endemic α-coronavirus while enhancing entry of SARS-CoV and MERS-CoV β-coronaviruses (Huang et al., 2011; Zhao et al., 2018) .

With respect to COVID-19, several studies have associated blood group A in the ABO system with disease severity (Mathew D, 2020) , although the mechanisms of this effect are not yet clear. ABO system associations with infectious diseases have also been shown for infections with noroviruses, H. pylori, and falciparum malaria; however, any such associations might also be indirect markers for unrelated genes. Newer data are beginning to define human immonotype risks J o u r n a l P r e -p r o o f 36 for more sever disease (Mathew D, 2020) , as well as posssible genetic signatures of severe diseases (Gussow AB, 2020) . At this time, data establishing specific genetic susceptibilities remain inconclusive for most diseases, including coronavirus diseases. This is a research area likely to be important in the future, since identification of susceptibilities for human disease severity has great implications for prevention, diagnosis, and treatment.

disease emergences/re-emergences are those associated with human behaviors, e.g., population growth, crowding, human movement, and (Dobson AP, 1996; Fauci and Morens, 2012; Morens et al., 2020b; Morens and Fauci, 2012; Morens et al., 2004 Morens et al., , 2008a Morens DM, 2020 ), e.g., the Serbian typhus epidemic during World War I, which killed 150,000 people, mostly civilians. In the 1700s, when typhus had not been identified as a specific disease, textbooks listed two separate conditions under the nosologic terms "war typhus" and "jail typhus", reflecting human activities that provoked long-ago disease emergences.

A classic epidemiology text published over a century ago, still studied today, is titled Epidemics Resulting from Wars (Prinzing, 1916) .

It is suspected that SARS-CoV-2 emerged in 2019, as did SARS-CoV in 2002, and as did H5N1 and H7N9 poultry-associated influenza, in 1997 and 2013, respectively, from wet markets in China (Morens et al., 2020a; Morens et al., 2020b) . These four diseases may thus represent four deadly emergences, within an 18-year span, from one cultural practice in one region of the world. These and many other examples (Dobson AP, 1996; Fauci and Morens, 2012; Lu et al., 2020; Morens et J o u r n a l P r e -p r o o f 41 al., 2020b; Morens and Fauci, 2012; Morens et al., 2004 Morens et al., , 2008a Morens et al., , 2019 Morens DM, 2020; Zhang and Holmes, 2020; Zhou et al., 2020b) constitute a powerful argument that human activities and practices have become the key determinant of disease emergence.

Whatever human behaviors lead to the emergence of infectious diseases, the newly emerged organism cannot survive continually in humans without adapting to one of several direct or indirect mechanisms of person-to-person spread (Table 4) (Table 4) In this context, ongoing research into the origin of SARS-CoV-2 seeks to learn where, how, and why the virus emerged as a human J o u r n a l P r e -p r o o f 44 pandemic disease (Boni et al., 2020; Latinne et al., 2020) . SARS-CoV-2 clusters phylogenetically within an extensive but still not fully characterized universe of wild bat β-coronaviruses found in many species over much of the globe (Anthony et al., 2017; Cui et al., 2019; Hu et al., 2017; Letko et al., 2020; Lu et al., 2020; Morens et al., 2020a; Zhang and Holmes, 2020; Zhou et al., 2020b) . The discovery that its closest identified viral relatives are enzootic in horseshoe (Rhinolophus) bats (Zhou et al., 2020a; Zhou et al., 2020b) indicates that SARS-CoV-2 probably emerged from an as yet unidentified bat reservoir either directly, or after infection of an intermediate host such as a pangolin (Boni et al., 2020; Letko et al., 2020; Li et al., 2020; Zhou et al., 2020a; Zhou et al., 2020b) . As was true of SARS-CoV 18 years ago, the specific determinants of SARS-CoV-2 emergence remain obscure. Gaining a better understanding of the enormous reservoir of bat coronaviruses has been an urgent priority since the 2002 SARS epidemic, and remains so today. Considerable surveillance, phylogenetic, and experimental J o u r n a l P r e -p r o o f 45 work remains to be done. In 2020, it is among our most urgent research priorities (Latinne et al., 2020) . (Geoghegan and Holmes, 2018) . In the latter conceptualization, viral quasispecies evolve together as a diverse array of optimally fit, less optimally fit, and least optimally fit variants, trading off perfect host fitness for adaptational flexibility.

While it has long been assumed that the major determinants of host-switching are the evolutionary closeness of hosts A and B and the diversity of their transmitting quasispecies, recent research suggests that pathogen opportunity may be the major determinant of hostswitching (Anishchenko et al., 2006; Araujo et al., 2015) . In essence, even a virus poorly fit to a potential host can adapt to infect that host if given enough chances. The implications are profound. If hostswitching is opportunity-driven, e.g., for SARS-CoV and CoV-2, Nipah, and Hendra, then prevention and control will have to focus not only on the infectious agents themselves, but also on human behaviors, such as the animal-human interface, represented by shopping in live animal markets, preparation and consumption of bush meat, intensive J o u r n a l P r e -p r o o f 49 farming/animal husbandry, environmental degradation, and other human behaviors (Allen et al., 2017; Carroll et al., 2018) .

Looked at another way, infectious diseases may be emerging into humans with greater frequency than appreciated; however, historically they have not usually achieved sustained enough transmission that would lead to detection of the emergence. For example, before the recognized emergence of Zika, low human seroprevalence rates had been detected in enzootic areas for decades, but without detection of human outbreaks. Before the emergence of SARS-C0V-2, antibodies to it or to closely-related sarbecoviruses were detected in humans exposed to bat coronaviruses (Wang et al., 2018) ; MERS has emerged from dromedary camels to humans on multiple occasions; however, despite limited chains of subsequent human-to-human spread, has not become an established human disease. H5N1 avian influenza has infected millions of humans; however, only a small percentage manifest a recognized disease (often severe or fatal), and human-to-human J o u r n a l P r e -p r o o f 50 transmission has been rarely reported (Morens and Taubenberger, 2015) . These and many other examples suggest that disease emergence into humans may be common; however, sustained transmission between humans has been a rare occurrence resulting from incompletely understood factors. But in looking at the recent spate of deadly emergences noted above, we must now ask whether human behaviors that perturb the human-microbial status quo have reached a tipping point that forecasts the inevitability of an acceleration of diseases emergences.

Such enigmas need to be better understood if we are to control emergences of infectious diseases (Dobson et al., 2020) and technological approaches to understand viral evolution and even predict emergence potential (Allen et al., 2017) .

There are many examples where disease emergences reflect our increasing inability to live in harmony with nature. Nipah virus emergence followed agricultural burning of forests, which led to displacement of infected bats; bats then went to roost in trees that shaded intensively-farmed pigs that were crowded into small areas, J o u r n a l P r e -p r o o f 52 which led to infection of pigs via bat droppings, which in turn led to human outbreaks in pig farmers (Morens et al., 2004) . Fish meal farming by Asian fishermen in waters around the globe damages ecosystems by over-fishing and deprives local residents of food sources, leading to poverty and human movement, which exacerbate the potential for disease emergence. In Asia, the fishmeal is used for breeding and over-feeding of farmed animals, often in intensive farming practices, which increase the likelihood of zoonotic diseases.

Yellow fever, dengue, chikungunya and Zika are all associated with urban crowding, poor sanitation, and water storage. Over many centuries, urbanization and crowding has led to rodent infestation and to rodent-borne diseases such as plague, murine typhus, and rat-bite fever. The ongoing COVID-19 pandemic reminds us that overcrowding in dwellings and places of human congregation (sports venues, bars, restaurants, beaches, airports), as well as human geographic movement, catalyzes disease spread.

J o u r n a l P r e -p r o o f 53 Living in greater harmony with nature will require changes in human behavior as well as other radical changes that may take decades to achieve: rebuilding the infrastructures of human existence, from cities to homes to workplaces, to water and sewer systems, to recreational and gatherings venues. In such a transformation we will need to prioritize changes in those human behaviors that constitute risks for the emergence of infectious diseases. Chief among them are reducing crowding at home, work, and in public places, as well as minimizing environmental perturbations such as deforestation, intense urbanization, and intensive animal farming. Equally important are ending global poverty, improving sanitation and hygiene, and reducing unsafe exposure to animals, so that humans and potential human pathogens have limited opportunities for contact. It is a useful "thought experiment" to note that until recent decades and centuries, many deadly pandemic diseases either did not exist, or were not significant problems. Cholera, for example, was not known in the West until the late 1700s, and became pandemic only because of human J o u r n a l P r e -p r o o f 54 crowding and international travel, which allowed new access of the bacteria in regional Asian ecosystems to the unsanitary water and sewer systems that characterized cities throughout the Western World.

This realization leads us to suspect that some, and probably very many of the living improvements achieved over recent centuries, come at a high cost that we pay in deadly disease emergences. Since we cannot return to ancient times, can we at least use lessons from those times to bend modernity in a safer direction? These are questions to be answered by all societies and their leaders, philosophers, builders, thinkers, and those involved in appreciating and influencing the environmental determinants of human health. (Organization, 2020) . The data show that beginning in March 2020 the pandemic exploded in Europe and the Americas, particularly in the United States, was blunted in these two regions between March and May, 2020, and then began to explode anew in the Americas and to a lesser extent in Europe beginning in late May. Since May, 2020, the pandemic has been increasing significantly in the SEARO (Asia and parts of Southeast Asia) region. Table 2 . Major Categories of Emerging Infectious Diseases. Not included above are currently established endemic diseases that are presumed to have been newly emerging at some time in the past, and then went on to develop long-term persistence in human or animal populations (see text). Table. Selected infectious diseases that have either been eradicated, are now being targeted for eradication, or are being significantly controlled by public health and medical or veterinary actions. Lower Table. Human infectious diseases that are currently considered non-eradicable, but for which some important disease aspects could potentially be eliminated with existing tools (e.g., eliminating human rabies without or before eradicating rabies in wild animals). The information is based on published data reflecting 2008 determinations (www.cartercenter.org.), supplemented by additional widely available publications. Columns show disease features which favor eradicability (blue circles), are of uncertain relevance to eradicability (yellow circles), or are expected to make eradication more difficult or impossible (red circles). Some of these features (e.g., ease of detecting disease and immunity, seasonality in tropical v. temperate climates) are subjective and situationally variable; see text and references for the individual diseases. *Sterile immunity for life refers to the ability of a natural infection or vaccine to induce a type and degree of immunity that prevents infection/reinfection and eliminates carriage and transmissibility to others and to animal and environmental reservoirs. Figure 3 . Infectious Agents, Hosts, and the Environment: Determinants of Disease Emergence and Persistence. Diseases, including emerging diseases, result from interactions between infectious agents, hosts, and the environment Adapted from Morens and Fauci, 2012; Morens et al., 2004 Morens et al., , 2008a . Figure 4 . Variable Mechanisms of Viral Entry into Host Cells. Examples of cell receptors for various DNA and RNA viruses. The cartoon image shows a spherical cell with different receptors for different categories of selected viruses. Viruses and cells are not reflective of relative sizes. The figure is suggested by the text and images of (Jayawardena et al., 2020) . Table 4 . Mechanisms of Infection Transmission from Person-to-Person and from Animal-to-Person. Selected endemic and emerging infectious diseases transmitted to humans via multiple mechanisms. The disease examples in red include new/important emergences and reemergences in the past four decades. Many diseases are transmitted by more than one mechanism. For example, most of the respiratorytransmitted diseases are also transmitted by hands and on fomites; most of the gastro-intestinal diseases are uncommonly transmitted directly, and more commonly transmitted by water, food, and on fomites. Some enteroviruses are predominantly transmitted by the fecal-oral (gastro-intestinal) route, whereas others are predominantly transmitted by the respiratory route. Anthrax is transmitted by respiratory, gastro-intestinal, and inoculation routes. Understanding mechanisms of transmission is important not only because it helps control those diseases that emerge, but also because it provides opportunities to control multiple diseases transmitted by the same mechanisms.

1 MERS is largely a zoonotic disease, although person-to-person spread can occur with relative inefficiency 2 Anthrax is largely acquired by inoculation of, or ingestion of spores, but the pulmonary form of anthrax can be spread person-to-person 3 Dracunculiasis is environmentally acquired as part of a complex life cycle including human expulsion of pathogens into the water and water-borne transmission to other humans Figure 5 . Proposed Molecular Mechanisms of Host-Switching. Proposed mechanisms of cross-species host-switching of infectious agents [after (Kuiken et al., 2006) ). Figures A and B represent steep (A) and shallow (B) fitness valleys between donor and recipient host species, reflecting adaptational barriers that need to be crossed. A and C show that a greater number of sequential adaptational mutations are needed in A to cross the fitness valley and then adapt to the new host, as compared to the situation shown in B and D, where greater donor-host similarities facilitate switching. C and D represent the associated phylogenetic trees: in C, the donor host and recipient host viruses most go through significant adaptational steps, including those associated with initial transmission in the new host. In D, the new host receives an infectious agent that is partially pre-adapted; successful emergence requires fewer adaptational mutations.

Global hotspots and correlates of emerging zoonotic diseases

The proximal origin of SARS-CoV-2

Venezuelan encephalitis emergence mediated by a phylogenetically predicted viral mutation

Global patterns in coronavirus diversity

Understanding Host-Switching by Ecological Fitting

Evolution of cell recognition by viruses

The Pathogenesis of Ebola Virus Disease

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic

Poliovirus Receptor: More than a simple viral receptor

The Global Virome Project

Accumulated measles virus mutations in a case of subacute sclerosing panencephalitis: interrupted matrix protein reading frame and transcription alteration

Principles of Epidemiology in Public Health Practice, Third Edition

HIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIV

Hosts and Sources of Endemic Human Coronaviruses

Origin and evolution of pathogenic coronaviruses

Host receptors: the key to establishing cells with broad viral tropism for vaccine production

The Selfish Gene

Infectious diseases and human population history

Ecology and economics for pandemic prevention

Mapping the Evolutionary Potential of RNA Viruses

The principles and feasibility of disease eradication

IFITM3 restricts the morbidity and mortality associated with influenza

The perpetual challenge of infectious diseases

Zika Virus in the Americas -Yet Another Arbovirus Threat

Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans

Evolutionary Virology at 40

Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin

Disease eradication

Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus

Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus

SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement

Virus-Receptor Interactions and Virus Neutralization: Insights for Oncolytic Virus Development

Origins and evolutionary consequences of ancient endogenous retroviruses

Host species barriers to influenza virus infections

Origin and cross-species transmission of bat coronaviruses in China

Flavivirus Receptors: Diversity, Identity, and Cell Entry. Front Immunol 9

Bat-borne virus diversity, spillover and emergence

Emergence of SARS-CoV-2 through Recombination and Strong Purifying Selection. bioRxiv

Vacated niches, competitive release and the community ecology of pathogen eradication

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Vaccinia epidemic and epizootic in El Salvador

SARS-like WIV1-CoV poised for human emergence

The Sverdlovsk anthrax outbreak of 1979

Decoding type I and III interferon signalling during viral infection

Antibody-dependent enhancement of infection and the pathogenesis of viral disease

The Origin of COVID-19 and Why It Matters

Escaping Pandora's Box -Another Novel Coronavirus

Emerging infectious diseases in 2012: 20 years after the institute of medicine report

The challenge of emerging and re-emerging infectious diseases

Emerging infections: a perpetual challenge

Eastern Equine Encephalitis Virus -Another Emergent Arbovirus in the United States

Pandemic influenza: certain uncertainties

How low is the risk of influenza A(H5N1) infection?

Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness

Preparing for Pandemics in the Modern World

The function of local lymphoid tissues in pulmonary immune responses

Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2

Epidemiology of Seasonal Coronaviruses: Establishing the Context for the Emergence of Coronavirus Disease

Specific and nonspecific host adaptation during arboviral experimental evolution

Cross-species virus transmission and the emergence of new epidemic diseases

Epidemics Resulting From Wars

Will the polio niche remain vacant?

A Zika virus envelope mutation preceding the 2015 epidemic enhances virulence and fitness for transmission

Antibody-mediated enhancement of viral disease

The 1918 influenza pandemic: 100 years of questions answered and unanswered

From smallpox eradication to the future of global health: innovations, application and lessons for future eradication and control initiatives

Sequential adaptive mutations enhance efficient vector switching by Chikungunya virus and its epidemic emergence

Fatal attraction: vegetation responses to nutrient inputs attract herbivores to infectious anthrax carcass sites

Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures

Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization

Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry

Serological Evidence of Bat SARS-Related Coronavirus Infection in Humans

Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates

Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2

Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins

Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever

Host range and emerging and reemerging pathogens

Emerging pathogens: the epidemiology and evolution of species jumps

Interferon-Induced Transmembrane Protein 3 Inhibits Hantaan Virus Infection, and Its Single Nucleotide Polymorphism rs12252 Influences the Severity of Hemorrhagic Fever with Renal Syndrome

Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus

Transmembrane Protein 3 Genetic Variant rs12252-C Associated With Disease Severity in Coronavirus Disease

A Genomic Perspective on the Origin and Emergence of SARS-CoV-2

Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses

A Novel Bat Coronavirus Closely Related to SARS-CoV-2 Contains Natural Insertions at the S1/S2 Cleavage Site of the Spike Protein

A pneumonia outbreak associated with a new coronavirus of probable bat origin